Melanocortin system
The melanocortin system is a pleiotropic neuroendocrine signaling axis built on a single prohormone — proopiomelanocortin (POMC) — whose tissue-specific post-translational processing generates at least six bioactive peptides: ACTH, alpha-MSH (alpha-melanocyte-stimulating hormone), beta-MSH, gamma-MSH, beta-endorphin, and beta-lipotropin. These peptides signal through five G-protein-coupled receptors (MC1R–MC5R) and are endogenously antagonized by two inverse agonists, AgRP and ASIP. The system coordinates a broad functional portfolio: skin pigmentation, adrenal cortisol secretion, energy homeostasis, appetite suppression, thermoregulation, and immunomodulation 1 2.
In the aging context, the melanocortin system is relevant across three intersecting domains: (1) the age-associated decline of hypothalamic POMC neuron tone, which contributes to anorexia of aging and sarcopenia via MC4R; (2) attenuated MC1R signalling in aged melanocytes, which impairs photoprotection and DNA-damage responses; (3) the anti-inflammatory potential of short POMC-derived peptides — particularly KPV — at MC3R/MC4R and via receptor-independent NF-kB suppression. This page is a navigational MOC; quantitative claims live on the atomic entity pages linked below.
System architecture
POMC: one prohormone, multiple products
POMC (UniProt P01189; NCBI Gene 5443) is a 241-amino-acid precursor expressed predominantly in the anterior pituitary corticotrophs, hypothalamic arcuate nucleus (ARC) POMC neurons, and — at lower levels — peripheral tissues including skin keratinocytes and immune cells. The peptide products generated by prohormone convertase (PC1 and PC2) cleavage depend on tissue context 2:
| Tissue | Primary PC enzyme | Key products |
|---|---|---|
| Anterior pituitary corticotrophs | PC1 | ACTH, beta-LPH |
| Hypothalamic ARC | PC1 + PC2 | alpha-MSH, beta-endorphin, gamma-MSH |
| Skin (keratinocytes, melanocytes) | PC1 + PC2 | alpha-MSH (UV-induced) |
| Immune cells | PC1 | alpha-MSH, ACTH |
The C-terminal tripeptide of alpha-MSH (KPV, residues 11-13) retains anti-inflammatory activity and can act independently of canonical MC receptor binding — see kpv.
Receptor inventory
| Receptor | Gene | Agonist preference | Primary tissues | Aging relevance |
|---|---|---|---|---|
| MC1R | MC1R | alpha-MSH, ACTH | Melanocytes, NK cells, macrophages | Skin photoprotection; photoaging risk modifier; see mc1r |
| MC2R | MC2R | ACTH only | Adrenal cortex | Cortisol secretion; ACTH resistance may emerge with age; see mc2r (stub) |
| MC3R | MC3R | alpha/beta/gamma-MSH, ACTH | Hypothalamus, gut, heart | Energy-sensing feedback; circadian metabolic coordination; anti-inflammatory; see mc3r (stub) |
| MC4R | MC4R | alpha-MSH | Hypothalamic PVN, brainstem, spinal cord | Appetite suppression, sarcopenia, cardiometabolic regulation; see mc4r |
| MC5R | MC5R | alpha-MSH | Exocrine glands, immune cells, skeletal muscle | Sebum secretion; immune modulation; see mc5r (stub) |
Inverse agonists
Two endogenous antagonists compete with MSH peptides at MC3R and MC4R and constitutively suppress signaling even in the absence of agonist:
- AgRP (Agouti-related protein) — expressed in ARC AgRP/NPY neurons, which tonically suppress appetite-inhibiting POMC neurons via GABAergic inputs; AgRP rises in energy deficit states, opposing alpha-MSH at MC3R and MC4R. needs-canonical-id — no AgRP protein page exists yet.
- ASIP (Agouti signaling protein) — expressed in skin and adipose; primary antagonist at MC1R in peripheral tissues, regulating pigmentation switch between eumelanin (brown/black) and phaeomelanin (red/yellow). needs-canonical-id — no ASIP protein page exists yet.
Signaling mechanism
All five MC receptors couple primarily to Gs, elevating intracellular cAMP via adenylyl cyclase activation — see camp-signaling. Downstream:
- Elevated cAMP activates PKA, which phosphorylates CREB and drives transcriptional programs dependent on receptor and cell type (MITF in melanocytes via MC1R; MC4R-mediated suppression of feeding-circuit neuropeptides in PVN neurons).
- MC3R and MC4R also recruit beta-arrestin for internalization and receptor desensitization.
- KPV and select alpha-MSH fragments can suppress NF-kB and MAPK activity via receptor-independent mechanisms — see nf-kb and kpv.
Aging-context summary
1. POMC neuron decline and anorexia of aging
Hypothalamic ARC POMC neuron number and activity decline progressively with age in rodent models 2. Reduced alpha-MSH tone at MC4R in the paraventricular nucleus (PVN) contributes to:
- Anorexia of aging — paradoxically, older individuals often develop voluntary food restriction (distinct from energy malnutrition) partly attributable to blunted appetite-regulation signaling feedback.
- Sarcopenia — MC4R signaling regulates skeletal muscle protein catabolism; reduced MC4R activation correlates with the accelerated muscle wasting seen in aging. See mc4r for quantitative data and citations.
The POMC neuron decline intersects with the deregulated-nutrient-sensing hallmark and connects upstream to insulin-igf1 (leptin/insulin signals converge on POMC neuron activity).
2. Photoaging and MC1R
UV radiation induces alpha-MSH production by keratinocytes, which signals via MC1R on neighboring melanocytes to upregulate eumelanin synthesis (photoprotection). Loss-of-function MC1R variants (common in fair-skinned populations) blunt this response, increasing UV-induced DNA damage and melanoma risk. Age-related decline in melanocyte number and MC1R density compounds this. See mc1r for variant data and citations.
3. Anti-inflammatory role via MC3R/MC4R and KPV
Alpha-MSH and its derivatives suppress inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) through MC3R and MC4R in macrophages and hypothalamic microglia. This anti-inflammatory arm connects the melanocortin system to the chronic-inflammation and altered-intercellular-communication hallmarks. The tripeptide KPV retains these effects with improved bioavailability — see kpv for mechanistic detail and citation to primary sources.
4. HPA axis intersection
ACTH, the pituitary POMC cleavage product, drives adrenal cortisol via MC2R. Age-related HPA axis dysregulation (elevated basal cortisol, blunted stress response) reflects upstream changes in hypothalamic CRH/AVP neurons rather than MC2R failure per se — the MC2R/ACTH/cortisol sub-axis is relatively preserved in healthy aging. See hpa-axis (stub) for context.
Therapeutic landscape
This system is druggable at tier 1 — multiple clinical-stage agents exist targeting individual receptors 3:
| Agent | Target | Indication | Stage | Wiki page |
|---|---|---|---|---|
| Afamelanotide (Scenesse) | MC1R agonist | Erythropoietic protoporphyria (EPP); photoprotection | FDA-approved (EPP) | — (no wiki page yet) |
| Setmelanotide (Imcivree) | MC4R agonist | Monogenic obesity (POMC/LEPR/PCSK1 deficiency) | FDA-approved | — (no wiki page yet) |
| Melanotan II (MT-II) | MC1R/MC3R/MC4R/MC5R pan-agonist | Tanning; ED (investigational) | Preclinical/research-only | melanotan-ii |
| alpha-MSH / analogs | MC1R–MC5R | Inflammation, neuroprotection (investigational) | Preclinical | alpha-msh |
| KPV | MC3R/MC4R + receptor-independent | IBD, anti-inflammatory aging (investigational) | Preclinical | kpv |
For aging-specific applications, no agent has completed a dedicated aging-indication trial targeting the melanocortin system as a whole. Afamelanotide’s EPP indication and setmelanotide’s monogenic-obesity indication do not constitute aging-indication trial coverage. needs-human-replication — aging-targeted MC agonist trials are absent.
Receptor ligand selectivity summary
Ligand selectivity across the five receptors varies substantially 3:
- ACTH — binds all five, but is the only endogenous agonist at MC2R (which lacks a binding pocket for shorter MSH peptides).
- alpha-MSH — high affinity at MC1R, MC3R, MC4R, MC5R; low at MC2R.
- beta-MSH — highest affinity at MC4R; relevant to energy homeostasis independently of alpha-MSH.
- gamma-MSH — preferential MC3R agonist; regulates sodium homeostasis in the kidney alongside energy balance.
- AgRP — inverse agonist at MC3R and MC4R only (not MC1R, MC2R, MC5R).
- ASIP — inverse agonist at MC1R; some activity at MC4R.
Cross-references
Atomic entity pages in this R35/R36 cluster:
- pomc — seeded 2026-05-09; full page available (unverified)
- alpha-msh — seeded 2026-05-09; full page available
- mc1r — seeded 2026-05-09; full page available
- mc4r — seeded 2026-05-09; full page available
- kpv — seeded; full page available
- melanotan-ii — seeded; full page available
Implicit stubs surfaced by this page (not yet seeded):
- agrp — AgRP inverse agonist protein page
- asip — ASIP inverse agonist protein page
- mc2r — MC2R adrenal receptor stub
- mc3r — MC3R energy/anti-inflammatory receptor stub
- mc5r — MC5R exocrine/immune receptor stub
- hypothalamic-arcuate-circuit — ARC circuit MOC
- hpa-axis — HPA axis pathway page
- melanogenesis — downstream process page
- appetite-regulation — downstream process page
- camp-signaling — cAMP second-messenger pathway
Limitations and gaps
- needs-canonical-id — KEGG does not have a dedicated melanocortin-system pathway map (hsa04080 neuroactive ligand-receptor does not include MC receptors in its current annotation).
kegg: nulluntil a specific entry is confirmed. - needs-canonical-id — WikiPathways ID not confirmed (search returned 403);
wikipathways: nulluntil verified. - needs-human-replication — No aging-indication clinical trial targeting the melanocortin axis as a whole has been registered or completed. Evidence for aging-relevant effects is derived from rodent models, receptor-genetics studies, and monogenic-disease trials.
- stub — AgRP, ASIP, MC2R, MC3R, MC5R protein pages do not yet exist; their claims are deferred to those future pages. POMC page exists but is unverified.
- Reactome R-HSA-388601 is a DefinedSet (“Melanocortin receptors [plasma membrane]”) — a set of receptor entities, not a Pathway or Reaction. Its parent pathway context is R-HSA-500792 (“GPCR ligand binding”; confirmed via Reactome ContentService 2026-05-09). The most relevant sibling reactions are R-HSA-388596 (“Melanocortin receptors bind melanocortins”) and R-HSA-388605 (“POMC(138-176) binds MC2R”). Reactome does not have an aging-specific POMC neuron pathway entry.
Footnotes
Footnotes
-
doi:10.1016/j.bbadis.2013.05.004 · Girardet C, Butler AA · BBA Molecular Basis of Disease 2014 · review · neural melanocortin receptors in obesity; MC4R as most frequent monogenic obesity cause; MC3R in circadian metabolic coordination ↩
-
doi:10.1038/s42255-021-00345-3 · Quarta C et al · Nature Metabolism 2021 · review · n=N/A (review) · POMC neuron heterogeneity and functional diversity; tissue-specific POMC processing; arcuate-nucleus aging changes ↩ ↩2 ↩3
-
doi:10.1530/jme-15-0292 · Dores RM et al · Journal of Molecular Endocrinology 2016 · review · 60 years of POMC; melanocortin receptor evolution; ligand selectivity across MC1R–MC5R ↩ ↩2